[Aripiprazol. An atypical neuroleptic with exceptional mechanisms of action] ].
Oberpichler-Schwenk
Heike
H
Redaktion Medizinische Monatsschrift für Pharmazeuten, Stuttgart. hoberpichler@deutscher-apotheker-verlag.de
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000068180:Aripiprazole; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010879:Piperazines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D015363:Quinolones / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole